Pfizer Inc.
PFIZER INC. $49 is a buy. The company (New York symbol PFE; Income-Growth Dividend Payer Portfolio, Manufacturing sector; Shares outstanding: 5.6 billion; Market cap: $274.4 billion; Dividend yield: 3.3%; Dividend Sustainability Rating: Highest; www.pfizer.com) is one of the world’s largest makers of prescription drugs....
TELUS CORP., $32.13, Toronto symbol T, is a buy.
The company is Canada’s second-largest wireless carrier, with 11.42 million users. That’s just behind BCE’s Bell Mobility (with 11.71 million users) and ahead of Rogers Communications (11.30 million users)....
The company is Canada’s second-largest wireless carrier, with 11.42 million users. That’s just behind BCE’s Bell Mobility (with 11.71 million users) and ahead of Rogers Communications (11.30 million users)....
Danaher is a great example of how a company can unlock value for shareholders with spinoffs. Since 2016, the conglomerate has completed two separate spinoffs. In that time, the stock has jumped over 280% compared to just 115% for the S&P 500 Index.
More spinoffs are possible—Danaher currently has over 20 different operating companies....
More spinoffs are possible—Danaher currently has over 20 different operating companies....
PFIZER INC., $50.78, New York symbol PFE, is your #1 Income Buy for 2022.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
MCDONALD’S CORP., $256.09, New York symbol MCD, is your #1 Conservative Buy for 2022.
The company is the world’s largest fast-food chain with over 39,000 restaurants in 119 countries. It serves a wide variety of food but is best known for its hamburgers and french fries....
The company is the world’s largest fast-food chain with over 39,000 restaurants in 119 countries. It serves a wide variety of food but is best known for its hamburgers and french fries....
Here are your three top U.S. stock picks for 2022—one each from our Conservative, Aggressive and Income portfolios.
In light of ongoing COVID-19 uncertainty, this year we are zeroing in on resilient stocks that have successfully adapted to the pandemic to thrive....
In light of ongoing COVID-19 uncertainty, this year we are zeroing in on resilient stocks that have successfully adapted to the pandemic to thrive....
GLAXOSMITHKLINE PLC ADRs $46 is a spinoff buy. The company (New York symbol GSK; Manufacturing sector; ADRs outstanding: 2.7 billion; Market cap: $124.2 billion; Dividend yield: 4.7%; Takeover Target Rating: Medium; www.gsk.com) is a U.K.-based global healthcare firm that develops and sells products in three main markets: pharmaceuticals (50% of 2020 revenue), vaccines (21%) and consumer healthcare (29%).
In June 2021, Glaxo announced that it would spin off its consumer operations as a separate firm; it owns 68% of this business, with Pfizer Inc....
In June 2021, Glaxo announced that it would spin off its consumer operations as a separate firm; it owns 68% of this business, with Pfizer Inc....
J.P. MORGAN CHASE & CO., $157.89, New York symbol JPM, remains a buy.
The stock lets investors tap the largest banking firm in the U.S., with total assets of $3.74 trillion as of December 31, 2021.
The bank continues to take back the funds it set aside in early 2020 to cover potential bad loans as a result of the COVID-19 lockdowns.
In the fourth quarter of 2021, due to those reversals, the bank recorded a net credit of $1.29 billion....
The stock lets investors tap the largest banking firm in the U.S., with total assets of $3.74 trillion as of December 31, 2021.
The bank continues to take back the funds it set aside in early 2020 to cover potential bad loans as a result of the COVID-19 lockdowns.
In the fourth quarter of 2021, due to those reversals, the bank recorded a net credit of $1.29 billion....
Johnson & Johnson recently announced that it would spin off its consumer drug business as a separate firm. This follows several other big pharmaceutical firms, including Pfizer, GlaxoSmithKline and Merck, that have completed similar spinoffs.
The breakup will let Johnson & Johnson focus on its more-profitable prescription drug and medical device operations; that’s key as creating new drugs is more complex than enhancing existing over-the-counter products.
Even though the consumer business has lower profit margins, its strong brands (some of which have been around for decades) should continue to generate steady cash flows....
The breakup will let Johnson & Johnson focus on its more-profitable prescription drug and medical device operations; that’s key as creating new drugs is more complex than enhancing existing over-the-counter products.
Even though the consumer business has lower profit margins, its strong brands (some of which have been around for decades) should continue to generate steady cash flows....
Just over a year ago, Pfizer folded its generic drug business into a new company called Viatris. The plan lets it better focus on its more-profitable products, particularly its COVID-19 vaccine. While Viatris is off to a slow start, it still has long-term appeal.
PFIZER INC....
PFIZER INC....